October 11, 2017 / 12:57 PM / a year ago

Aerie's glaucoma drug effectively lowers eye pressure-FDA review

Oct 11 (Reuters) - Aerie Pharmaceuticals Inc’s experimental glaucoma treatment Rhopressa is effective in lowering eye pressure, a preliminary review by the U.S. Food and Drug Administration concluded.

The review, posted on Wednesday on the FDA’s website, comes two days ahead of a meeting of outside experts who will advise the agency on whether the treatment should be approved.

Glaucoma, a condition caused by damage to the optic nerve, is the second-leading cause of blindness in the world. It is expected to affect more than 4 million Americans by 2030, up from 2.7 million today. (Reporting by Toni Clarke in Washington; Editing by Chizu Nomiyama)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below